Fair Value Calculator Fair Value Calculator
EN DE

NICCOPAR (NICCOPAR) Fair Value & Analysis

IN · Market cap ₹3.7B

N NICCOPAR NICCOPAR · BSE
Price₹79.01
Fair Value₹24.50
Upside-69.0%
Quality45/100
Watch NICCOPAR for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹13.02 – ₹35.99

Fair value as of: Jul 5, 2026

From 8 valuation models · updated today

Share price +25.2% over the past month.

Price vs Fair Value (12 months)

₹115.56 ₹59.60 Fair Value ₹24.50 Jun 2025 Jul 2026

12‑month range ₹59.60 – ₹115.56 · fair‑value band ₹13.02 – ₹35.99 · the ₹79.01 price screens above the ₹24.50 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

NICCOPAR (NICCOPAR) currently trades at ₹79.01, while our model-based Fair Value estimate is ₹24.50 — implying the stock looks roughly 69.0% overvalued today. We read business quality at 45/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, NICCOPAR generated revenue of ₹663M at a net margin of -4.1%. Revenue declined 12.7% year over year. It earns a return on equity of -2.6%. Net debt stands at ₹14.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹13.02 (bear case) to ₹35.99 (bull case); at ₹79.01, the current price sits above that range. The share trades about 34% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹663M
Revenue growth (YoY) -12.7%
Net margin -4.1%
Return on equity -2.6%
Free cash flow −₹106M FY2026
Operating margin -7.7%
More key figures
EPS (TTM) ₹-0.5800
Dividend yield 1.6%
EPS growth (YoY) -80.8%
Net debt ₹14.1M FY2020

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

NICCOPAR reported revenue of ₹657M in FY2026 versus ₹309M in FY2022, a compound +20.7%/yr. Reported net income was −₹27.3M in FY2026.

Revenue +20.7%/yr
FY22 ₹309M
FY23 ₹756M
FY24 ₹785M
FY25 ₹742M
FY26 ₹657M
Net income
FY22 ₹48.7M
FY23 ₹225M
FY24 ₹248M
FY25 ₹224M
FY26 −₹27.3M

Is NICCOPAR fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "NICCOPAR Fair Value". https://www.fairvalue-calculator.com/stock/NICCOPAR

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is NICCOPAR (NICCOPAR) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹24.50 versus a price of ₹79.01 — about −69% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NICCOPAR?
Our model-based fair value for NICCOPAR is ₹24.50 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹79.01.
What is the quality score of NICCOPAR?
NICCOPAR has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of NICCOPAR (NICCOPAR)?
NICCOPAR reported trailing-twelve-month revenue of about ₹663M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of NICCOPAR?
The net profit margin of NICCOPAR is about -4.1%, meaning it is currently running at a net loss. Based on the latest reported figures.
Does NICCOPAR pay a dividend?
NICCOPAR currently shows a dividend yield of about 1.56% relative to its recent price (as of Jul 5, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.